Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program.

BACKGROUND The use of critical pathways for a variety of clinical conditions has grown rapidly in recent years, particularly pathways for patients with acute coronary syndromes (ACS). However, no systematic review exists regarding the value of critical pathways in this setting. METHODS The National Heart Attack Alert Program established a Working Group to review the utility of critical pathways on quality of care and outcomes for patients with ACS. A literature search of MEDLINE, cardiology textbooks, and cited references in any article identified was conducted regarding the use of critical pathways for patients with ACS. RESULTS Several areas for improving the care of patients with ACS through the application of critical pathways were identified: increasing the use of guideline-recommended medications, targeting use of cardiac procedures and other cardiac testing, and reducing the length of stay in hospitals and intensive care units. Initial studies have shown promising results in improving quality of care and reducing costs. No large studies designed to demonstrate an improvement in mortality or morbidity were identified in this literature review. CONCLUSIONS Critical pathways offer the potential to improve the care of patients with ACS while reducing the cost of care. Their use should improve the process and cost-effectiveness of care, but further research in this field is needed to determine whether these changes in the process of care will translate into improved clinical outcomes.

[1]  A. Shroyer,et al.  Fast-track cardiac surgery in a Department of Veterans Affairs patient population. , 1997, The Annals of thoracic surgery.

[2]  A. Gawlinski,et al.  Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). , 2001, The American journal of cardiology.

[3]  J. Mcmanus Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial: The TIMI IIIB Investigators Circulation 89:1545–1556 Apr 1994 , 1994 .

[4]  C. Cannon,et al.  Critical pathways : a review. Committee on Acute Cardiac Care, Council on Clinical Cardiology, American Heart Association. , 2000, Circulation.

[5]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[6]  D. Sackett,et al.  Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.

[7]  K. Lee,et al.  Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. , 1994, The New England journal of medicine.

[8]  A. Yeung,et al.  Effect of audit on door-to-inflation times in primary angioplasty/stenting for acute myocardial infarction. , 2001, The American journal of cardiology.

[9]  E J Topol,et al.  Readiness for the scorecard era in cardiovascular medicine. , 1995, The American journal of cardiology.

[10]  A. Joseph Chest pain centers. , 1997, Clinics in laboratory medicine.

[11]  Daniel B. Mark,et al.  Acute Coronary Care , 1985, Springer US.

[12]  C. Cannon,et al.  Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators. , 1999, The American journal of cardiology.

[13]  H. Katus,et al.  The prognostic value of serum troponin T in unstable angina. , 1992, The New England journal of medicine.

[14]  W. O’Neill,et al.  Regional variation across the United States in the management of acute myocardial infarction. , 1995, The New England journal of medicine.

[15]  B. Garbin Introduction to clinical pathways. , 1995, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

[16]  A R Zinsmeister,et al.  A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. , 1998, The New England journal of medicine.

[17]  J. Ornato,et al.  The Physician's Role in Minimizing Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction: Recommendations from the National Heart Attack Alert Program , 1997, Annals of Internal Medicine.

[18]  E F Cook,et al.  A computer protocol to predict myocardial infarction in emergency department patients with chest pain. , 1988, The New England journal of medicine.

[19]  L. Wallentin,et al.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999 .

[20]  A. Berman,et al.  Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. , 1997, American Journal of Cardiology.

[21]  L. Kampe,et al.  A national survey of emergency department chest pain centers in the United States. , 1998, The American journal of cardiology.

[22]  R. Roberts,et al.  An evaluation of a chest pain diagnostic protocol to exclude acute cardiac ischemia in the emergency department. , 1997, Archives of internal medicine.

[23]  P. Théroux,et al.  Aspirin, heparin, or both to treat acute unstable angina. , 1988, The New England journal of medicine.

[24]  C. Lambrew Emergency department triage of patients with nontraumatic chest pain , 1995 .

[25]  E. Braunwald,et al.  Unstable angina. A classification. , 1989, Circulation.

[26]  C. Cannon,et al.  One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. , 1995, Journal of the American College of Cardiology.

[27]  G. Lamas,et al.  A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. , 1993, The New England journal of medicine.

[28]  R. Roberts,et al.  Costs of an emergency department-based accelerated diagnostic protocol vs hospitalization in patients with chest pain: a randomized controlled trial. , 1997, JAMA.

[29]  W. Weaver,et al.  Long-term Outcome in Acute Myocardial Infarction Patients Admitted to Hospitals With and Without On-site Cardiac Catheterization Facilities , 1997 .

[30]  M. Hand 9-1-1 : rapid identification and treatment of acute myocardial infarction , 1995 .

[31]  B. Riegel,et al.  Effectiveness of a program of early hospital discharge of cardiac surgery patients. , 1996, The Journal of cardiovascular nursing.

[32]  L. Hillis,et al.  The use of aspirin in ischemic heart disease. , 1992, The New England journal of medicine.

[33]  T. Brennan,et al.  28th Bethesda Conference. Task Force 2: Guideline implementation. , 1997, Journal of the American College of Cardiology.

[34]  M D Hagen,et al.  An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group. , 1997, Annals of emergency medicine.

[35]  D Wybenga,et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.

[36]  R. Bahr Growth in chest pain emergency departments throughout the United States: a cardiologist's spin on solving the heart attack problem. , 1995, Coronary artery disease.

[37]  Thomas Lee,et al.  Critical Pathways as a Strategy for Improving Care: Problems and Potential , 1995, Annals of Internal Medicine.

[38]  E. Braunwald,et al.  One‐Year Results of the Thrombolysis in Myocardial Infarction Investigation (TIMI) Phase II Trial , 1992, Circulation.

[39]  B. McNeil,et al.  Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. , 1997, The New England journal of medicine.

[40]  L. Graff,et al.  Impact on the care of the emergency department chest pain patient from the chest pain evaluation registry (CHEPER) study. , 1997, The American journal of cardiology.

[41]  L Pilote,et al.  Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, The New England journal of medicine.

[42]  C. Cannon,et al.  The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. , 1997, Journal of the American College of Cardiology.

[43]  H. Krumholz,et al.  Use of critical pathways to improve the care of patients with acute myocardial infarction. , 1999, The American journal of medicine.

[44]  F. Harrell,et al.  Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia , 1996 .

[45]  M. LeWinter,et al.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.

[46]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[47]  G. Stone,et al.  Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. , 1998, Journal of the American College of Cardiology.

[48]  S. Roux,et al.  Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis. , 1992, Journal of the American College of Cardiology.

[49]  H. Krumholz,et al.  Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. , 1995, JAMA.

[50]  J. Stamler,et al.  Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. , 1986, Journal of the American College of Cardiology.

[51]  E. Braunwald,et al.  Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. , 1990, Journal of the American College of Cardiology.

[52]  E. Braunwald,et al.  Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. , 1996 .

[53]  E. Topol,et al.  A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. , 1988, The New England journal of medicine.

[54]  E. Braunwald,et al.  Results of the Treat Angina With Aggrastat and Determine the Cost of Therapy With an Invasive or Conservative Strategy (TACTICS-TIMI 18) Trial: A Comparison of Invasive Versus Conservative Strategy in Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction , 2000 .

[55]  J. Muhlestein,et al.  An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). , 1996, Journal of the American College of Cardiology.

[56]  Harlan M. Krumholz,et al.  Do “America's Best Hospitals” Perform Better for Acute Myocardial Infarction? , 1999 .

[57]  R. Califf,et al.  Scorecard Cardiovascular Medicine: Its Impact and Future Directions , 1994, Annals of Internal Medicine.

[58]  R. Califf,et al.  Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. , 1996, Journal of the American College of Cardiology.

[59]  K. Eagle,et al.  Evaluating and improving the delivery of heart care: the University of Michigan experience. , 1998, The American journal of managed care.

[60]  C M Gibson,et al.  Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. , 2000, JAMA.

[61]  J P Ornato,et al.  Comprehensive strategy for the evaluation and triage of the chest pain patient. , 1997, Annals of emergency medicine.

[62]  R B D'Agostino,et al.  A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. , 1984, The New England journal of medicine.

[63]  E F Cook,et al.  Prediction of the need for intensive care in patients who come to emergency departments with acute chest pain. , 1996, The New England journal of medicine.

[64]  Parmley Ww Do we practice geriatric cardiology , 1997 .

[65]  K. Fox,et al.  Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis. , 1992, BMJ.

[66]  Christopher P Cannon,et al.  Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry. , 2002, Critical pathways in cardiology.

[67]  J. Ornato,et al.  National Heart Attack Alert Program position paper: chest pain centers and programs for the evaluation of acute cardiac ischemia. , 2000, Annals of emergency medicine.

[68]  W. Weaver,et al.  The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators. , 1993, The New England journal of medicine.

[69]  L Goldman,et al.  A Critical Pathway for Management of Patients with Acute Chest Pain Who Are at Low Risk for Myocardial Ischemia: Recommendations and Potential Impact , 1997, Annals of Internal Medicine.

[70]  J. Gold,et al.  Cost containment in cardiac surgery: results with a critical pathway for coronary bypass surgery at the New York hospital-Cornell Medical Center. , 1996, Best practices and benchmarking in healthcare : a practical journal for clinical and management application.

[71]  J. Fleiss,et al.  Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.

[72]  L. Wilkins Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[73]  R. M. Rubison,et al.  Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. , 1994, Circulation.

[74]  C. Madden Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease: The RISC Group Lancet 336: 827–830 Oct 1990 , 1991 .

[75]  E. Braunwald,et al.  Two- and three-year results of the thrombolysis in myocardial infraction (TIMI) phaes II clinical trial , 1993 .

[76]  C. Cannon,et al.  Emergency department thrombolysis critical pathway reduces door‐to‐drug times in acute myocardial infarction , 1999, Clinical cardiology.

[77]  R. Califf,et al.  Identification of Acute Myocardial Infarction Patients Suitable for Early Hospital Discharge After Aggressive Interventional Therapy: Results From the Thrombolysis and Angioplasty in Acute Myocardial Infarction Registry , 1991, Circulation.